CDSCO issues alert against 62 substandard drugs; Samples from Lupin, Jackson Laboratories flagged
The Central Drugs Standard Control Organisation (CDSCO) has flagged 62 drug samples as they failed the quality test. The alert was issued by the drug regulator for November 2023. The drug regulator’s…
Dr Reddy’s gears up for weight loss drug study
Dr Reddy’s Laboratories has got a go-head from the Subject Expert Committee (SEC) under India’s drug regulatory authority to conduct a bioequivalence study required to establish the safety and efficacy of the blockbuster weight…
Second batch of Sputnik V Vaccine reaches
60,000 doses of Russia’s C-19 vaccine Sputnik V landed at Rajiv Gandhi International Airport here, Dr Reddy’s Laboratories said. “Pleased to share that the consignment that arrived today in Hyderabad contains 60,000 doses of the second…
DCGI approval for Sputnik V vaccine expected soon: Dr Reddy’s
Dr Reddy’s Laboratories expects the Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks, a company official has said. “We expect to get approval in…
Dr Reddy’s submits Indian trials data of Sputnik to DCGI
Hyderabad: Dr Reddy’s Laboratories, which has applied for emergency use authorisation (EUA) for Russian C-19 vaccine Sputnik V, has submitted data from the Indian Phase II/III trials as directed by the expert committee that…
Cipla Seeks Approval To Modify Remdesivir Composition To Reduce Renal Toxicity
Mumbai : The Mumbai headquartered pharma giant Cipla has sought approval from the subject expert committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) to modify Covid-19 drug remdesivir’s composition…
Dr Reddys hopes to finish Phase 3 trials of Covid-19 vaccine by March-May
Dr Reddys Laboratories on Wednesday said the Phase 3 trials of Russia’s Sputnik V vaccine for Covid-19 in India to be conducted by it are expected to be completed by the end of March…
Dr. Reddy seeks nod for DCGI approval for Phase 3 clinical trials of Sputnik V in India
Dr Reddy’s Laboratories has applied permission to the Drugs Controller General of India (DCGI) for conducting the phase-3 human clinical trials of Sputnik V, Russian coronavirus vaccine against COVID-19 in…
Threat to Indian pharmaceutical company, may cost more than 6 thousand crores in the US
A total of 44 US states on Monday filed a lawsuit against as many as 20 generic drug manufacturers, including seven Indian firms. Among these Indian firms, 5 have been…
